Mizuho Downgrades Pediatrix Medical Group to Underperform, Maintains Price Target to $28

Benzinga · 2d ago
Mizuho analyst Ann Hynes downgrades Pediatrix Medical Group (NYSE:MD) from Neutral to Underperform and maintains the price target from $28 to $28.